STAT

SEPTEMBER 2, 2022

Sometime this weekend or early next week, pharmacies and doctors’ offices are going to start to receive Covid-19 boosters that have been reformulated to include protection against one of the sub-variants of Omicron. These boosters, from Pfizer and its partner BioNTech as well as from Moderna, are bivalent shots. They target two strains of the SARS-CoV-2 virus, both the original strain that all previous vaccines have protected against, and the Omicron sub-variants BA.4/BA.5.

Vaccines 280

Vaccines 280

PharmaVoice

AUGUST 30, 2022

The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.

300

300

pharmaphorum

AUGUST 31, 2022

Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners. The original agreement last year focused on melanoma patients who are receiving BRAF/MEK combination therapies – specifically Novartis’ Tafinlar (dabrafenib) and Mekinist (trametinib) drugs – and has resulted in the development of a digital module tailored to their needs.

Chemotherapy 110

Chemotherapy Immunity Immunization Hospitals 110

Pharmaceutical Technology

SEPTEMBER 2, 2022

Novo Nordisk has signed a definitive agreement for the acquisition of clinical-stage biopharmaceutical firm Forma Therapeutics for $20 for each share in cash or a total equity price of $1.1bn. Forma focuses on researching, developing and marketing new therapies for patients with sickle cell disease (SCD), rare hematologic diseases and cancers. Through the acquisition, Novo Nordisk plans to boost its presence in sickle cell disease and rare blood disorders.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 1, 2022

As the country heads for its third autumn and winter with Covid-19, the forecasts are not auspicious. Given how transmissible the SARS-CoV-2 virus is, models anticipate more than 100,000 additional deaths by the time next summer rolls around. The toll will depend on whether new variants emerge and how humans behave. Will many Americans, for example, decide to get the new, Omicron-tailored booster that could be available as soon as this weekend?

Vaccines 268

Vaccines 268

PharmaVoice

AUGUST 29, 2022

A collaboration between Stanford University researchers and Komodo Health aims to advance knowledge of lingering COVID symptoms, health disparities and intervention strategies.

246

246

The Thyroid Pharmacist

SEPTEMBER 2, 2022

I often get asked if there is one thing that people with Hashimoto’s should do right away to feel better. My answer is always, “There are two! Get off gluten and balance your blood sugar levels!”. Balancing blood sugar levels should be one of the top priorities for anyone who is hoping to overcome autoimmune thyroiditis (and adrenal fatigue). It was one of the first interventions I tried when working to heal my own thyroid condition, and it made a big difference for me.

Diabetes 98

Diabetes Health and Personal Care Stores Immunity Immunization 98

STAT

SEPTEMBER 2, 2022

I have worn many hats professionally. The most uncomfortable one is “doctor friend.” At best, it’s a request for a recommendation for a gynecologist or for advice on which antihistamine works best for allergies. But other times I have found myself in the role of interpreter between a friend and their physician, navigating serious health problems.

264

264

PharmaVoice

AUGUST 29, 2022

Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.

246

246

European Pharmaceutical Review

AUGUST 30, 2022

Researchers from UPV/EHU-University of the Basque Country, Spain, have successfully produced different types of starch-based pharmaceutical tablets using 3D printing. The aim of the study, published in the International Journal of Pharmaceutics , was to produce 3D printed starch-based tablets for the tailored delivery of hydrophobic drugs. Hydrophobic drugs – those that poorly water soluble – account for some 40% of marketed drugs and the 60% of the drug candidates in research, the paper notes.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmaTech

AUGUST 28, 2022

In a new podcast titled, “DeltaV™ Spectral Process Analytical Technology (PAT): Achieve Real-Time, Closed-Loop PAT in Manufacturing,” find out how embedding PAT directly into the control system enables life sciences manufacturers to take a simplified approach to achieving real-time manufacturing, compliance with confidence, greater ROI and delivery of quality treatments to market faster.

98

98

STAT

AUGUST 31, 2022

The Food and Drug Administration on Wednesday authorized new Covid booster shots from Moderna and Pfizer that more closely match the strains of the coronavirus that are currently circulating in the U.S. Pfizer’s booster, made with partner BioNTech, is being authorized for people as young as 12 years old. The Moderna booster is being authorized for people ages 18 and up.

Vaccines 252

Vaccines 252

PharmaVoice

SEPTEMBER 1, 2022

A long-time analyst, Tycho Peterson brings his business savvy to the C-suite at Adaptive, where he began as CFO in June with a knowledge of what works and what doesn't in the diagnostics space.

243

243

Pharmaceutical Technology

AUGUST 28, 2022

Moderna has f iled patent infringement lawsuits in the US District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany against Pfizer and BioNTech over messenger ribonucleic acid (mRNA) technology. Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, is said to have infringed patents filed by Moderna between 2010 and 2016 for its mRNA technology.

Vaccines 98

Vaccines 98

Board Vitals - Pharmacist

AUGUST 31, 2022

The NFL season is finally here. While the players prepare for the game on the field, another team is watching for something more important off the field. Four specially trained “spotters” watch every game from the stadium press box and pull players who may have been involved in concussion-causing collisions. The reason is clear; the National Football League (NFL) reported 224 concussions in 2019.

97

97

STAT

SEPTEMBER 2, 2022

WASHINGTON — Rahul Gupta is no stranger to the nationwide addiction crisis. Drug use and overdose defined his tenure as the top health official in West Virginia, arguably the state hardest hit by the epidemic, and before that as the health officer in the state’s largest county.

246

246

PharmaVoice

AUGUST 30, 2022

The biotech says that its competitors’ COVID-19 vaccine copied proprietary mRNA technology. Here’s a breakdown of the case.

Vaccines 265

Vaccines 265

pharmaphorum

SEPTEMBER 1, 2022

Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. COVID-19 antiviral medications Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) must be taken within five days of the onset of symptoms, but obtaining these medications within that window is difficult for some.

Vaccines 96

Vaccines Online Pharmacies Drug Pricing 96

Pharma Times

AUGUST 30, 2022

Therapy is a biosimilar of Lucentis which treats several serious retinal diseases across the European Union

Biosimilars 117

Biosimilars 117

STAT

SEPTEMBER 1, 2022

Maria Van Kerkhove gets it. Truly, she knows you’re over Covid. The World Health Organization’s technical lead for Covid-19, Van Kerkhove understands that the world is struggling with a lot right now. Devastating flooding in Pakistan, famine in the Horn of Africa, war in Ukraine, monkeypox around the globe — there are too many demands for our attention and concern, for philanthropic and government funding.

Vaccines 246

Vaccines 246

PharmaVoice

AUGUST 31, 2022

Fresh off an eight-year tour of duty at ICON, the CRO industry veteran is stepping into a new role and a new title as chief delivery officer at Thread.

246

246

EMCrit Project

AUGUST 27, 2022

Historically, many patients admitted with congestion due to heart failure have been treated with furosemide monotherapy. However, a strategy of furosemide monotherapy has numerous drawbacks: Furosemide tends to stimulate production of dilute urine, leading to a greater amount of water loss than sodium loss. Predominant loss of water may cause loss of volume from the […].

95

95

pharmaphorum

AUGUST 30, 2022

Neurocrine Biosciences has featured on lists of potential takeover candidates for years, but has now taken the lead on a buyout of UK biotech Diurnal that if consummated will extend its therapeutic focus further into hormonal disorders. The 27.5 pence-a-share cash deal values Diurnal at around £48.3 million ($57 million), a 144% premium to the biotech’s closing share price on Friday.

94

94

STAT

SEPTEMBER 1, 2022

Much of the public’s perceptions around food as an intervention for health are dated. So are the U.S. government’s perceptions and its health care policies. Not by a matter of years, but by decades. The last time the nation focused on food — from the top — was the 1969 White House Conference on Food, Nutrition, and Health.

Labelling 246

Labelling 246

PharmaVoice

AUGUST 29, 2022

The biosimilar developer is advancing a pipeline with high growth potential, including a copycat of Humira.

Biosimilars 265

Biosimilars 265

Digital Pharmacist

SEPTEMBER 2, 2022

It’s hard to believe that the COVID-19 pandemic started over two years ago. Since then, many new SARS-CoV-2 variants have emerged and have been infecting populations across the world. Experts from organizations like the CDC strongly recommend that as many people get vaccinated as possible to prevent the spread of more contagious or deadlier variants over time.

Vaccines 93

Vaccines Pharmacy Management Communication Immunity 93

pharmaphorum

AUGUST 30, 2022

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial programme will investigate the potential of asundexian in up to 30,000 patients with atrial fibrillation (AF) as well as patients with a non-cardioembolic ischaemic stroke or high-risk transient ischemic attack (TIA), said Bayer.

Compounding 93

Compounding 93

STAT

AUGUST 31, 2022

Despite a recent taxpayer-subsidized boon , the hospital industry spent the last several months lobbying for additional federal dollars amid warnings about the continued spread of Covid-19 and inflation’s impact on the nation’s health care system. Those efforts bore fruit: Medicare recently granted hospitals the largest price increase since 1998.

Hospitals 242

Hospitals 242

PharmaVoice

SEPTEMBER 1, 2022

Pfizer's $5.4 billion deal to acquire Global Blood Therapeutics invigorated the fast-growing market, and patients are fit to be the benefactors.

148

148

PioneerRx

AUGUST 29, 2022

As more and more pharmacies look to move beyond dispensing and into providing clinical care services, it is important that you take advantage of the opportunity.

97

97

pharmaphorum

SEPTEMBER 1, 2022

AstraZeneca has succeeded in a last-gasp effort to stop its former head of investor relations joining rival UK pharma group GSK, after winning an injunction in the High Court in London. Chris Sheldon ended an almost 19-year career at AZ in August, working his way up from a lab role and holding a series of senior positions at the company, most recently as head of investor relations.

90

90

STAT

SEPTEMBER 1, 2022

An expert committee that advises the Centers for Disease Control and Prevention on vaccine policy voted on Thursday to recommend use of updated Covid-19 vaccines. With the positive votes from the Advisory Committee on Immunization Practices, the issue now goes to CDC Director Rochelle Walensky. If she signs off on the recommendation — and she is expected to do so, possibly Thursday evening — the new boosters will be cleared for use.

Vaccines 237

Vaccines Immunity Immunization 237

PharmaVoice

AUGUST 29, 2022

Crystal clear communication is becoming more important for businesses working in our increasingly connected world.

Communication 130

Communication 130

PioneerRx

AUGUST 29, 2022

After you’ve signed the papers and sealed the deal on your new brick-and-mortar, you can breathe a sigh of relief. With one step down, you’re one step closer to.

97

97

European Pharmaceutical Review

AUGUST 29, 2022

What are the clients’ goals in seeking out a personalised culture media solution? Oftentimes, our clients’ goals are to increase cell growth, improve protein titers and optimise product quality attributes. Biopharmaceutical manufacturers find that custom media can provide tailored solutions. What are some of the challenges manufacturers face? Discussion often exposes significant problems with lot-to-lot consistency with current media suppliers and scale-up to supply all their manufacturing sites

Process Improvement 90

Process Improvement 90